Perceptic haalt 12 miljoen dollar op voor AI-platform dat medicijnonderzoek automatiseert

Perceptic, founded by three former Palantir Life Sciences executives, has launched an AI platform automating the entire drug development process from discovery through clinical trials. The London-based startup secured $12 million in seed funding led by Accel, with participation from Air Street Capital and Elder Gull.